[go: up one dir, main page]

AU2002253000A1 - Inflammation-inhibiting compounds - Google Patents

Inflammation-inhibiting compounds

Info

Publication number
AU2002253000A1
AU2002253000A1 AU2002253000A AU2002253000A AU2002253000A1 AU 2002253000 A1 AU2002253000 A1 AU 2002253000A1 AU 2002253000 A AU2002253000 A AU 2002253000A AU 2002253000 A AU2002253000 A AU 2002253000A AU 2002253000 A1 AU2002253000 A1 AU 2002253000A1
Authority
AU
Australia
Prior art keywords
inflammation
inhibiting compounds
inhibiting
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002253000A
Other versions
AU2002253000B2 (en
Inventor
Thomas Luger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10106852A external-priority patent/DE10106852A1/en
Application filed by Individual filed Critical Individual
Publication of AU2002253000A1 publication Critical patent/AU2002253000A1/en
Application granted granted Critical
Publication of AU2002253000B2 publication Critical patent/AU2002253000B2/en
Priority to AU2006203622A priority Critical patent/AU2006203622B2/en
Assigned to BRZOSKA, THOMAS, GRABBE, STEPHAN, LUGER, THOMAS reassignment BRZOSKA, THOMAS Request for Assignment Assignors: LUGER, THOMAS
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002253000A 2001-02-14 2002-02-08 Inflammation-inhibiting compounds Ceased AU2002253000B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2006203622A AU2006203622B2 (en) 2001-02-14 2006-08-22 Inflammation-inhibiting compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10106852.2 2001-02-14
DE10106852A DE10106852A1 (en) 2001-02-14 2001-02-14 Anti-inflammatory compounds
PCT/EP2002/001323 WO2002064131A2 (en) 2001-02-14 2002-02-08 Inflammation-inhibiting compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006203622A Division AU2006203622B2 (en) 2001-02-14 2006-08-22 Inflammation-inhibiting compounds

Publications (2)

Publication Number Publication Date
AU2002253000A1 true AU2002253000A1 (en) 2003-02-20
AU2002253000B2 AU2002253000B2 (en) 2006-05-25

Family

ID=7674019

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002253000A Ceased AU2002253000B2 (en) 2001-02-14 2002-02-08 Inflammation-inhibiting compounds
AU2006203622A Ceased AU2006203622B2 (en) 2001-02-14 2006-08-22 Inflammation-inhibiting compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2006203622A Ceased AU2006203622B2 (en) 2001-02-14 2006-08-22 Inflammation-inhibiting compounds

Country Status (17)

Country Link
US (4) US8003608B2 (en)
EP (6) EP2189156A1 (en)
JP (1) JP4259870B2 (en)
CN (3) CN1269477C (en)
AT (2) ATE358475T1 (en)
AU (2) AU2002253000B2 (en)
CA (1) CA2437788C (en)
CY (4) CY1106563T1 (en)
DE (3) DE10106852A1 (en)
DK (4) DK1749524T3 (en)
ES (4) ES2361422T3 (en)
MX (1) MXPA03007255A (en)
NZ (2) NZ528191A (en)
PL (3) PL223478B1 (en)
PT (4) PT2196202E (en)
SI (4) SI2196202T1 (en)
WO (1) WO2002064131A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10106852A1 (en) 2001-02-14 2002-09-05 T Luger Anti-inflammatory compounds
WO2002096947A2 (en) * 2001-05-25 2002-12-05 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw The lectin-like domain of thrombomodulin and its therapeutic use
US20090232866A1 (en) 2003-10-07 2009-09-17 Mariann Pavone-Gyongyosi Oligopeptides as coating material for medical products
WO2006009325A1 (en) * 2004-07-23 2006-01-26 Ono Pharmaceutical Co., Ltd. Metalloprotease inhibitor
JPWO2006046746A1 (en) * 2004-10-26 2008-05-22 味の素株式会社 Visceral pain prevention / treatment agent
WO2007004613A1 (en) 2005-07-01 2007-01-11 Ajinomoto Co., Inc. THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-α PRODUCTION INHIBITOR
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
DE102006003854A1 (en) * 2006-01-26 2007-08-02 Universität Duisburg-Essen Preparation of regulatory and cytotoxic CD8+ T cells, useful for treatment and prevention of immune reactions and associated disease, by treating naive cells with alpha-melanocyte-stimulating hormone
US20100286056A1 (en) * 2007-11-19 2010-11-11 Boehm Markus Compositions for reducing oxidative stress and uses thereof
US9156881B2 (en) 2011-09-23 2015-10-13 Westfaelische Wilhelms-Universitaet Muenster Tripeptide KDPT for antiapoptotic treatment
KR20140136494A (en) 2012-03-20 2014-11-28 헬릭스 바이오메딕스, 인코포레이티드 Short antimicrobial lipopeptides
BR112015027569A2 (en) * 2013-05-10 2017-09-19 Southern Res Inst compounds, compositions, methods and their uses for treating disease by inhibiting tgf-ß activity
RU2669939C2 (en) 2013-09-23 2018-10-17 Др.Аугуст Вольфф Гмбх Унд Ко.Кг Арцнаймиттель Tripeptides
US10383911B2 (en) 2013-11-07 2019-08-20 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Storage stable lyophilized tripeptide formulations
CN107349416A (en) * 2017-08-01 2017-11-17 中山大学 A kind of Hyanalgese-D thing containing tripeptide compound
EP3682892A4 (en) * 2017-09-15 2021-10-27 Kine Sciences Co., Ltd. USE OF PEPTIDES AS A THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES AND BONE DISEASES
CN111150831B (en) * 2020-02-27 2023-06-09 广州领晟医疗科技有限公司 Application of polypeptide KdPT
US11793746B2 (en) * 2020-10-01 2023-10-24 Chanda Zaveri Intense skin hydration systems and methods
CN114432421B (en) * 2022-01-12 2024-04-12 广州领晟医疗科技有限公司 KdPT polypeptide for treating acute lung injury and application thereof
CN114404562A (en) * 2022-01-17 2022-04-29 广州领晟医疗科技有限公司 A KdPT polypeptide for treating osteoarthritis and its application

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000833A2 (en) 1986-08-08 1988-02-11 Board Of Regents, The University Of Texas System Antipyretic and anti-inflammatory peptides
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
ATE125548T1 (en) 1988-03-28 1995-08-15 British Tech Group PEPTIDES.
ES2012532A6 (en) * 1988-07-15 1990-04-01 Cusi Lab Ophthalmic aqueous solutions containing lysine- alpha -methyl-4-(2'-thionylcarbonyl) phenyl acetate
DE3844046A1 (en) * 1988-12-28 1990-07-05 Hoerrmann Wilhelm Pharmaceutical compositions which contain isomers of hydroxylysine or lysine
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
SG86971A1 (en) * 1990-11-30 2002-03-19 Teijin Ltd 2-arylthiazole derivatives and pharmaceutical composition thereof
EP0680321B1 (en) * 1993-01-22 1998-09-23 Pfizer Inc. Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
GB9413935D0 (en) * 1994-07-11 1994-08-31 Peptech Uk Ltd Use of maramyl peptide compounds
GB9419011D0 (en) * 1994-09-21 1994-11-09 Peptech Uk Ltd Use of muramyl peptide compounds
SE9500270L (en) 1995-01-25 1996-09-09 A K J Medi Konsult Ab Medicines for deficiency conditions
EP0806947A4 (en) * 1995-02-03 1998-10-14 Cosmederm Technologies Formulations and methods for reducing skin irritation
FR2733421B1 (en) 1995-04-28 1997-06-06 Oreal USE OF DERIVATIVES OF THE STIMULATING HORMONE OF MELANOCYTES OF THE ALPHA TYPE TO STIMULATE OR INDUCE HAIR GROWTH AND / OR STOP THEIR FALLING
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US5939394A (en) * 1996-01-18 1999-08-17 Fleming & Company Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
JP3567350B2 (en) 1996-03-13 2004-09-22 株式会社ホーネンコーポレーション Anti-alopecia
JP3922594B2 (en) 1996-03-19 2007-05-30 株式会社ノエビア Antibacterial hypoallergenic cosmetic
CZ389398A3 (en) * 1996-05-29 1999-07-14 Prototek, Inc. Thalidomide promedicaments and their use for modulation or t-cell function
US6117896A (en) * 1997-02-10 2000-09-12 Molecumetics Ltd. Methods for regulating transcription factors
EP0934924B1 (en) * 1996-10-11 2008-08-13 Kowa Co. Ltd. Novel diamide compounds and drugs containing the same
AUPO713297A0 (en) * 1997-06-02 1997-06-26 Fujisawa Pharmaceutical Co., Ltd. Oxazole compound
SE9801571D0 (en) * 1998-05-05 1998-05-05 Wapharm Ab Melanocortin-1 receptor selective compounds
FR2784028B1 (en) * 1998-10-01 2003-02-07 Oreal USE OF A PEPTIDE FOR PREVENTING SKIN INTOLERANCE REACTIONS, ESPECIALLY IN COSMETIC COMPOSITIONS
JP3962166B2 (en) 1998-10-19 2007-08-22 株式会社資生堂 Topical skin preparation
WO2000037071A1 (en) * 1998-12-21 2000-06-29 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
CA2359636A1 (en) * 1999-01-22 2000-07-27 Andrew W. Taylor Activation of regulatory t cells by alpha-melanocyte stimulating hormone
WO2000054750A1 (en) 1999-03-15 2000-09-21 Dmitry Anatolievich Starchenko Method for correcting disturbance in collagen synthesis and biologically active substance for realising the same
AU7593001A (en) * 2000-07-14 2002-01-30 Zycos Inc Alpha-msh related compounds and methods of use
DE10106852A1 (en) 2001-02-14 2002-09-05 T Luger Anti-inflammatory compounds
JP4226909B2 (en) 2001-05-11 2009-02-18 財団法人化学及血清療法研究所 Peptide having cytopathic inhibitory activity and screening method for peptide having cytopathic inhibitory activity

Similar Documents

Publication Publication Date Title
AU2002349297A1 (en) Statin-like compounds
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2002360508A1 (en) Substituted hydroxyethylamines
AU2002253000A1 (en) Inflammation-inhibiting compounds
AU2002359165A1 (en) Novel compounds
AUPR878201A0 (en) New compounds
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AUPR920301A0 (en) Neurologically-active compounds
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2004201666B2 (en) 4-Imidazolin-2-one compounds
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2002251553A1 (en) Heterocyclic compounds
AU2002363108A1 (en) 4-imidazolin-2-one compounds
AU2002337136A1 (en) Isocyanato-isocyano compounds
AU2002306300A1 (en) Azasugar compounds
AU2002235881A1 (en) Compounds
AU2002346861A1 (en) Substituted 1h-quinolin-2-one compounds
AU2002249205A1 (en) Bis-triazinylaminobenzoxazole derivatives
AU2002350425A1 (en) 6-phenyldihydropyrrolopyrimidinedione derivatives
AU2002354530A1 (en) 4-phenylpyran-2-one derivatives
AU2002325368A1 (en) Benzoylcyclohexenone derivatives
HK1062431A (en) A-amino-n-hydroxy-acetamide derivatives
AU2002305184A1 (en) Cycloalkenylsulfonamide derivatives